Contact
searchSearch
HMP Global

abstracts

Sarcopenia is Associated with Social Determinants of Health in Patients with Inflammatory Bowel Disease
BACKGROUND: Sarcopenia is defined as the loss of skeletal muscle mass and is a modifiable condition that affects between 27 to 61% of patients with inflammatory bowel disease (IBD). Socia...
12/15/2022
P072 Non-invasive Vagal Nerve Stimulation to Treat Crohn Disease and Ulcerative Colitis in Children and Young Adults: A Proof-of-Concept Clinical Trial
BACKGROUND: Current inflammatory bowel disease (IBD) therapies are limited by incomplete efficacy, loss of response, side effects and high costs. Vagal nerve stimulation (VNS)...
12/15/2021
P073 Diagnostic Outcome of Patients With Non-Specific Colitis
BACKGROUND: Colitis describes inflammation in the colon and is classified into defined diseases: Inflammatory bowel disease (IBD), Microscopic colitis, Ischemic colitis and In...
12/15/2021
P074 Comparative Risk of Clostridioides Difficile Infection in Vedolizumab vs anti-TNFa Agents in Biologic-Naïve Patients With Ulcerative Colitis
BACKGROUND: Clostridioides difficile infection (CDI) is associated with adverse outcomes in ulcerative colitis (UC). There is concern that vedol...
12/15/2021
P064 Association Between Crohn's Disease (CD) and Transient IgM and IgG Immunodeficiency—Diagnostic and Management Challenges
CASE: Background: CD is an inflammatory disease that predominantly affects the gastrointestinal tract and has a progressive course. Immunodeficiencies can occur by altering di...
12/15/2021
P075 Urgency and its Association with Quality of Life and Clinical Outcomes in Ulcerative Colitis Patients
BACKGROUND: Urgency, the immediate need to defecate, is common in ulcerative colitis (UC). The frequently used patient reported outcome (PRO)-2 for UC includes only rectal ble...
12/15/2021
P065 A One-Time Education for Gastroenterologists Regarding Osteoporosis Screening for IBD Patients Improves Provider Knowledge But Not Screening Rates
BACKGROUND: Inflammatory Bowel Disease (IBD) is a chronic gastrointestinal inflammatory condition and has been increasing in prevalence in the United States, with a 30-40% inc...
12/15/2021
P076 The Role of Dual Biologic Therapy in Inflammatory Bowel Disease
BACKGROUND: As the prevalence of complex inflammatory bowel disease and extraintestinal manifestations continue to rise, more patients are requiring complex treatment regimens...
12/15/2021
P066 Real-World Experience of Ustekinumab in Crohn's Disease Patients With Prior Anti-TNF Therapy at a Tertiary Care Hospital
BACKGROUND: Ustekinumab (UST) is a monoclonal antibody against the p40 subunit of IL-12/23. It is approved for the treatment of moderate to severe Crohn's disease (CD) and Ulc...
12/15/2021
P077 Incidence of Colonic Strictures — A Systematic Review and Meta-analysis
BACKGROUND: Intestinal strictures are a complication of the inflammatory bowel diseases (IBD, including ulcerative colitis (UC) and Crohn’s disease (CD)) that can lead to bowe...
12/15/2021

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use